Cadence Wealth Management’s Boston Scientific BSX Stock Holding History

Cadence Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$370K	Hold	5,890	–	–	0.15%	46
2025 Q4	$562K	Hold	5,890	–	–	0.27%	37
2025 Q3	$575K	Hold	5,890	–	–	0.3%	36
2025 Q2	$633K	Hold	5,890	–	–	0.42%	31
2025 Q1	$594K	Hold	5,890	–	–	0.44%	25
2024 Q4	$526K	Hold	5,890	–	–	0.35%	28
2024 Q3	$494K	Hold	5,890	–	–	0.4%	25
2024 Q2	$454K	Hold	5,890	–	–	0.32%	30
2024 Q1	$403K	Hold	5,890	–	–	0.41%	26
2023 Q4	$341K	Hold	5,890	–	–	0.27%	29
2023 Q3	$311K	Hold	5,890	–	–	0.26%	30
2023 Q2	$319K	Hold	5,890	–	–	0.31%	23
2023 Q1	$295K	Buy	+5,890	New	+$278K	0.3%	21

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cadence Wealth Management's BSX Position: Q1 2026 in Review

Cadence Wealth Management held its Boston Scientific (BSX) position steady in Q1 2026 at 5,890 shares worth $370K. The position accounts for 0.15% of the portfolio, ranked #46.

Cadence Wealth Management first reported a position in BSX in Q1 2023 and has held it in 13 quarters since. The position peaked at $633K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Cadence Wealth Management held 5,890 shares of Boston Scientific worth $370K as of Q1 2026.
Cadence Wealth Management left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.15% of Cadence Wealth Management's portfolio in Q1 2026, its #46 holding.
Cadence Wealth Management first reported a position in Boston Scientific in Q1 2023 and has held it in 13 quarters since.
Cadence Wealth Management's Boston Scientific position peaked at $633K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cadence Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.